FPL-55712 FREE BASE

Details

Stereochemistry	RACEMIC
Molecular Formula	C27H30O9
Molecular Weight	498.5217
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCC1=C(O)C(=CC=C1OCC(O)COC2=CC=C3C(=O)C=C(OC3=C2CCC)C(O)=O)C(C)=O

InChI

InChIKey=LMQBMWHHGVZWMR-UHFFFAOYSA-N

InChI=1S/C27H30O9/c1-4-6-19-22(10-8-17(15(3)28)25(19)31)34-13-16(29)14-35-23-11-9-18-21(30)12-24(27(32)33)36-26(18)20(23)7-5-2/h8-12,16,29,31H,4-7,13-14H2,1-3H3,(H,32,33)

HIDE SMILES / InChI

Molecular Formula	C27H30O9
Molecular Weight	498.5217
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Cysteinyl leukotriene receptor 1 18 Target ID: Q9Y271 Gene ID: 10800.0 Gene Symbol: CYSLTR1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/6695994 \| https://www.ncbi.nlm.nih.gov/pubmed/6322240	Antagonist 2849

PubMed

Title	Date	PubMed
Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.	1991-04	1855116
The effect of a leukotriene receptor antagonist, FPL 55712, on estrogen-induced uterine hyperemia in the nonpregnant rabbit.	1984-02-15	6695994

Substance Class	Chemical Created by `admin` on `Tue Apr 01 21:11:39 GMT 2025` Edited by `admin` on `Tue Apr 01 21:11:39 GMT 2025`
Record UNII	8Q3M8GL2XV
Record Status	`Validated (UNII)`
Record Version